Carotid bodies are the principal peripheral chemoreceptors for detecting changes in arterial blood oxygen levels, and the resulting chemoreflex is a potent regulator of blood pressure. Recurrent apnea with intermittent hypoxia (IH) is a major clinical problem in adult humans and infants born preterm. Adult patients with recurrent apnea exhibit heightened sympathetic nerve activity and hypertension. Adults born preterm are predisposed to early onset of hypertension. Available evidence suggests that carotid body chemoreflex contributes to hypertension caused by IH in both adults and neonates. Experimental models of IH provided important insights into cellular and molecular mechanisms underlying carotid body chemoreflex-mediated hypertension. This article provides a comprehensive appraisal of how IH affects carotid body function, underlying cellular, molecular, and epigenetic mechanisms, and the contribution of chemoreflex to the hypertension.
Introduction
Seminal studies by Fernando de Castro (32) and Cornielle F. Heymans (73) demonstrated that carotid bodies, which are located at the bifurcation of common carotid arteries are the sensory organs for detecting changes in arterial blood oxygen (O 2 ) levels, and the resulting reflex is a potent regulator of blood pressure. Heymans (74) further suggested that reflexes from aortic region might subserve a similar function. Subsequent studies by Julius H. Comroe Jr. established that reflexes arising from the aortic bodies, which are located in the aortic arch also regulate cardio-respiratory functions during hypoxia (26) . Thus, carotid and aortic bodies are regarded as the major peripheral chemoreceptors for detecting arterial blood O 2 levels and the ensuing reflexes maintain cardio-respiratory homeostasis during hypoxia. Tissues with a similar morphology to carotid and aortic bodies have also been described in thorax and abdomen, which are called "paraganglion," and might serve as additional chemoreceptors (34, 44) .
Amongst the peripheral chemoreceptors identified thus far, carotid bodies are the best studied with respect to the mechanisms of O 2 sensing and chemoreflex regulation of cardiorespiratory functions. Carotid body receives sensory innervation from a branch of the glossopharengeal nerve called the "carotid sinus nerve" (CSN). Hypoxia increases the CSN activity, which in turn reflexely stimulates breathing, sympathetic nerve activity and increases blood pressure. Earlier reviews on the mechanisms of O 2 sensing by the carotid body and the chemoreflex regulation of cardio-respiratory functions can be found in the articles by Fidone & Gonzalez (48) , and Fitzgerald & Lahiri (49) . A contemporary and comprehensive analysis of the carotid body and the chemoreflex function in health and disease is presented in a recent review article in the Comprehensive Physiology (99) .
Hypoxia, which is the primary stimulus to the carotid body, can be continuous such as that occurs during sojourn at high altitude or can be intermittent as experienced by those with sleep-disordered breathing with apnea (i.e., brief cessation of breathing). People with recurrent apnea exhibit several comorbidities including hypertension. A substantial body of evidence suggests that the carotid body chemoreflex contributes to hypertension caused by intermittent hypoxia (IH). Recent studies on experimental models of IH have provided important insights into cellular and molecular mechanisms underlying carotid body chemoreflex-mediated hypertension. The purpose of this article is to provide a comprehensive appraisal of how IH affects the carotid body function, underlying mechanisms, and the contribution of the chemoreflex to the hypertension.
IH and Sleep-Disordered Breathing with Apnea
IH is a hallmark manifestation of sleep-disordered breathing (SDB) with recurrent apnea, which is characterized by transient, repetitive cessations of breathing either due to obstruction of the upper airway (Obstructive Sleep Apnea, OSA) or defective generation of respiratory rhythm by the central nervous system (CNS) (central apnea) (133, 175) . In severely affected patients arterial blood saturations can be reduced to as low as 50%. Epidemiological studies showed that recurrent apnea is prevalent in nearly 5% of adult males and 2% of women after menopause. Apnea results in periodic hypoxemia (i.e., IH) and intermittent hypercapnia (i.e., elevated arterial CO 2 ). A major advance in the field of apnea research is the demonstration that exposing experimental animals to IH alone is sufficient to produce many of the comorbidities including hypertension (51) .
IH and Hypertension

Clinical findings
OSA patients exhibit pronounced increases in blood pressure during apneic episodes and elevated blood pressures during daytime even in the absence of apneas (155, 191) . OSA is particularly common in patients with resistant hypertension (43) . Peppard and co-workers demonstrated a clear correlation between the severity of apnea and subsequent development of hypertension independent of other comorbidities and confounding factors (155) . Thus, IH is a major factor contributing to hypertension in OSA patients.
Continuous positive airway pressure (CPAP) is the treatment of choice for OSA. However, the effectiveness of CPAP treatment in controlling hypertension in OSA patients is controversial. For instance, Dudenbostel and Calhoun (43) reported that CPAP treatment is ineffective in normalizing blood pressure in OSA patients with resistant hypertension. On the other hand, several others reported that CPAP treatment is effective in lowering blood pressure in OSA patients (8, 82, 181) . Taken together, these studies demonstrate that recurrent apnea patients exhibit exaggerated blood pressure elevations during apneic episodes and hypertension during daytime.
Studies on animal models
The English bulldog exhibits apneas during REM sleep (69) and obese pigs also show mild SDB with apnea (114, 194) . However, whether apnea in these animal models also leads to hypertension is not known. Fletcher (50) developed a rat model of IH, mimicking O 2 saturation profiles seen in recurrent apnea patients. Rats exposed to IH for 30 days develop hypertension (+11 mmHg) recapitulating the phenotype reported in recurrent apnea patients (50) . Subsequent studies have confirmed that rodents exposed to prolonged IH do indeed exhibit hypertension, but the magnitude and the onset of hypertension seem to depend on the paradigm of IH (Table 1) .
IH and Sympathetic Nerve Activity
Clinical findings
A growing body of evidence suggests that augmented sympathetic nerve activity is a major contributor to the hypertension in OSA patients. Muscle sympathetic nerve activity (MSNA) is reflective of systemic vascular resistance. Consequently, several investigators recorded MSNA in sleep apnea patients (14, 67, 110, 181) . Normal subjects without apneas exhibit low levels of MSNA during sleep (78, 136, 182) ; whereas sleep apnea patients display striking absence of reduced MSNA during sleep (131) . Sympathetic nerve activity and blood pressure increase progressively with each episode of apnea and the magnitude of increase is more pronounced during REM (rapid eye movement) sleep, wherein the duration of apneas are longer than in non-REM sleep (131) . OSA patients exhibit elevated MSNA during daytime despite the absence of apneas and normal arterial blood gases (131) . Exposing normal subjects to a daily regimen of IH for 10 days alone was sufficient to augment MSNA (115) . Acute IH akin to apneas leads to long-lasting sympathetic activation in normal subjects (30, 126, 195) , which might explain why sleep apnea patients exhibit increased sympathetic nerve activity during daytime. Elevated sympathetic nerve activity in OSA subjects is independent of obesity, which is a common comorbidity in these patients (131) . OSA patients exhibit elevated circulating and urinary catecholamines (both norepinephrine and epinephrine), which were attributed to increased sympathetic nerve activity (14, 54, 55, 120, 181) . CPAP treatment normalizes sympathetic nerve activity in OSA patients (8, 82, 181) . Collectively, these studies suggest that hypertension in recurrent apnea patients is associated with overactive sympathetic nervous system. However, endothelial dysfunction leading to altered vascular reactivity caused by IH is also proposed to contribute to systemic hypertension associated with OSA (4, 89) .
Studies on animal models
IH-exposed rats show elevated cervical (60) , renal (79) , splanchnic (40) , thoracic (204) , and lumbar (119) sympathetic nerve activity. Sympathetic nerve activation evoked by stimulation of the sciatic nerve or nasal mucosa was pronounced in IH-exposed rats (179) , suggesting that IH sensitizes sympathetic nerve responses to other stimuli. IH affects the coupling of sympathetic-respiratory outputs at the CNS. The increased sympathetic nerve activity by IH coincides with the late expiratory phase of respiration (40, 204) . A recent study by Moraes et al. (125) reported that a specific subpopulation of non-C1 respiratorymodulated rostral ventrolateral medullary (RVLM) presympathetic neurons exhibit enhanced excitatory synaptic inputs from the respiratory network, which may contribute to the increased sympathetic nerve activity in IH-exposed rats. Chemical sympathectomy with 6-OH dopamine prevents IH-induced hypertension (53) , suggesting that enhanced sympathetic nerve activity contributes to elevated blood pressure.
Carotid Body Chemoreflex and Sympathetic Activation by IH
Carotid body being exquisitely sensitive to hypoxia is uniquely suited to sense and respond to even a modest drop in pO 2 that occurs during brief episodes of IH associated with recurrent apnea. Consequently, it was proposed that carotid bodies constitute the "frontline" defense system for detecting periodic hypoxemia associated with apneas and the resulting chemoreflex contributes to sympathetic nerve activation (22) . The following section summarizes the role of carotid body chemoreflex in sympathetic activation by IH.
Clinical studies
Activation of the carotid body chemoreflex evokes sympatho-excitation in humans (29, 111, 177) . The following lines of evidence suggest that the carotid body chemoreflex is augmented in recurrent apnea patients. First, hypoxia-induced sympathetic excitation, stimulation of breathing, and increase in blood pressure, all of which are hallmarks of the chemoreflex, are more pronounced in recurrent apnea patients than in control subjects (68, 91, 132) . Second, in OSA patients, brief hyperoxic exposure, which decreases carotid body sensory activity, results in a more pronounced ventilatory depression (91, 189) and greater reduction in blood pressure (132) as compared with control subjects. Third, carotid body ablated subjects with sleep apneas do not develop hypertension [see "Discussion of the article" in reference (180) ]. Collectively, these studies suggest that recurrent apnea patients' exhibit heightened carotid body chemoreflex, which contributes to augmented sympathetic nerve activity.
Studies on animal models
Available evidence suggests that augmented carotid body chemoreflex also contributes to IH-induced sympathetic activation in experimental animals. IH-exposed cats (166) and mice (153) exhibit enhanced ventilatory response to hypoxia, a hallmark of carotid body chemoreflex. Huang et al. (79) reported exaggerated renal nerve responses to hypoxia and hypercapnia in rats exposed to 3 weeks of IH. Likewise, rats exposed to IH also exhibit enhanced thoracic sympathetic and phrenic nerve responses to cyanide, a potent stimulator of the carotid body in a working heart-brainstem preparation (12, 204) .
Processing of sensory information from the carotid body at the CNS is critical for translating the increased carotid body activity to appropriate reflex activation of the sympathetic nervous system. The dorsal and medial subnuclei of the nucleus tractus solitarius (NTS), including the commissural part of the NTS (cNTS), receive inputs from the CSN (20, 201) . Rats exposed to IH exhibit increased FosB/ΔFosB expression in the NTS and RVLM (97) as well as c-Fos protein expression in the dorsal and medial subnuclei of the NTS (178) . These findings indicate that IH activates brainstem regions that regulate sympathetic preganglionic neuronal activity via the carotid body chemoreflex.
Neuronal activity in cNTS is regulated by various neurotransmitters, including glutamate (Glu), an excitatory amino acid transmitter, and dopamine (DA), an inhibitory biogenic amine. IH upregulates N-methyl-D-aspartate receptor 1 (NMDA-R1) expression in the dorsocaudal brainstem (164) , Glu receptor types 2/3 subunit expression in cNTS (27) , and AMPA-and NMDA-mediated currents in NTS neurons (33) . On the other hand, IH downregulates tyrosine hydroxylase expression in the dorsal medulla, the rate-limiting enzyme in DA synthesis (59) . Since DA inhibits synaptic transmission at the NTS (96) , it is likely that IH, by downregulating the synthesis of DA, enhances glutamatergic excitatory transmission in the NTS (19) . Kline et al. (95) showed that IH not only increases postsynaptic neuronal activity in the NTS but also attenuates synaptic transmission between sensory afferents and the NTS second-order neurons. This effect seems to occur via reduced transmitter release involving calcium/calmodulin-dependent kinase II activation (95) .
Neurons in the NTS relay chemoafferent information to the hypothalamic paraventricular nucleus (PVN) and brain-stem sympathoexcitatory sites located in the RVLM (72, 173 ). An earlier study by Greenberg et al. (61) showed that IH alters neuronal activity of the ventrolateral medulla (A1 noradrenergic cells). Zoccal et al. (203) reported that IH-induced sympathetic activation is mediated by enhanced purinergic but not glutamatergic transmission in the RVLM of juvenile rats. On the other hand, Silva and Schreihofer (179) found that glutamatergic transmission in the RVLM is critical for the augmented sympathetic activation by IH in adult rats. These findings implicate that age is an important variable that determines the type of neurotransmitter(s) mediating the effects of IH on sympathetic activation by RVLM. A recent study by Coleman et al. (24) reported that PVN neurons in IH-exposed mice exhibit decreased NMDA-R-mediated currents, reduced nitric oxide (NO) production by NMDA, and downregulation of NMDA-receptors in neuronal NO synthase-positive neurons. Collectively, these studies indicate that the exaggerated chemoreflex-mediated sympathetic activation by IH involves reconfiguration of neurotransmitter profiles in the CNS.
Fletcher and his co-workers reported that ablation of CSNs prevents IH-induced hypertension (52, 109) . The CSN carries the sensory information from both baro-, and chemoreceptors. To delineate the contribution of chemoreceptors, Peng et al. (152) selectively ablated the carotid body using cryo-coagulation approach, while preserving the carotid baroreceptor function. Consistent with the earlier reports by Fletcher and his coworkers (52, 109) , selective carotid body ablation prevented IH-induced hypertension and abolished elevated plasma catecholamine levels in IH-exposed rats (152) .
OSA patients exhibit marked elevations in blood pressure during apneic episodes (81, 186) , which were attributed to the augmented sympathetic nerve activity affecting the vascular tone (92) . To assess whether carotid body activation during apneic episodes contributes to blood pressure elevations, Peng et al. (152) simulated apneas by exposing anesthetized rats to acute intermittent hypoxia (AIH; 12% O 2 for 15 s and then room air for 5 min, repeated for 10 cycles). Unlike the control rats, IH-exposed rats, similar to OSA patients, exhibited a marked elevation in blood pressures during each episode of AIH. Remarkably, selective ablation of the carotid bodies completely prevented the abnormal blood pressure increases seen with each episode of AIH (152) . These findings suggest that carotid body activation during apneic episodes mediates the abnormal increases in blood pressures during AIH via carotid body chemoreflex.
Effects of IH on Carotid Body Function
Increased carotid body sensory nerve activity is a prerequisite for initiating the chemoreflex. Consequently, several studies examined the effects of IH on the carotid body sensory nerve activity in experimental animals and delineated the underlying cellular and molecular mechanisms. The following section summarizes the findings from these studies.
IH and carotid body sensory nerve response to hypoxia
Carotid body sensory nerve response to hypoxia was examined in rats that were exposed to IH for 10 days (148) . Hypoxic sensory nerve response was augmented in IH-exposed rats as compared to those exposed to normoxia (Fig. 1 ). Similar effects of IH were also observed in cats (166) and mice (153) , suggesting that IH uniformly augments the hypoxic sensory response in three species studied thus far. The enhanced hypoxic sensory response was completely reversed following reoxygenation of IH-exposed rats (147) . In striking contrast, IH had no effect on carotid body response to hypercapnia (148) suggesting that IH leads to selective sensitization of the hypoxic response. Given that carotid chemoreflex is a potent activator of the sympathetic nervous system, it is likely that IH-induced augmented hypoxic sensitivity of the carotid body contributes to the pronounced increase in sympathetic nerve activity that occurs during each episode of IH.
Induction of sensory long-term facilitation of the carotid body by IH
In addition to the sensitization of the carotid body to hypoxia, IH induces a form of plasticity of the carotid body manifested as sensory long-term facilitation (LTF; 147). Acute IH (10 episodes of 15 s of 12% O 2 interspersed with 5 min of 95% O 2 ) progressively increased carotid body baseline sensory activity in IH-exposed rats, which persisted as long as an hour even after the termination of acute IH (Fig. 1) . The long-lasting increase in baseline sensory activity was observed despite maintaining arterial blood gas composition and blood pressure comparable to control, preacute IH period (147) . The time course of the carotid body sensory activity resembled that of LTF of breathing elicited by acute IH reported previously (124) and hence was referred to as sensory LTF. A notable difference between LTF of breathing and sensory LTF of the carotid body is that the former is seen in control naive rats in response to acute IH, wherein each episode of hypoxia lasts for 5 min. In contrast, sensory LTF of the carotid body is not seen in control, naive rats but requires prior exposure to IH for 10 days. However, a study by Cummings and Wilson (28) reported that acute intermittent hypocapnic hypoxia produces a weak sensory LTF in an in vitro perfused carotid body preparation from normoxia-exposed rats. Thus, these findings demonstrate that IH induces a hitherto uncharacterized novel form of carotid body plasticity manifested as sensory LTF. It was proposed that the sensory LTF of the carotid body mediates the persistent elevation of the sympathetic nerve activity seen in IH-exposed rats (161) . These studies establish that IH leads to remodeling of carotid body function manifested as sensitization of the hypoxic sensory response and induction of sensory LTF.
Factors affecting the carotid body response to IH
The effects of IH on the carotid body were seen only after three days of IH and the magnitude of the responses (i.e., sensitization of the hypoxic response and sensory LTF) further increased with ten days of IH exposure (147, 148) . Altering the severity of hypoxia used for IH conditions had little impact on the magnitude of the responses (147) . These studies demonstrate that the effects of IH on the carotid body developed over time and were independent of the severity of hypoxia used for IH conditioning.
Carotid body responses to IH are unique
The total duration of hypoxia accumulated over ten days of IH equals to 4 h of continuous hypoxia. However, either a single episode of 4 h of hypoxia or 4 h of hypoxia per day for 10 days were ineffective in either evoking sensitization of the hypoxic response or eliciting the sensory LTF (147, 148) . Thus, for a given duration of hypoxic exposure, IH is more effective than continuous hypoxia in altering the carotid body function. However, it has been reported that rats exposed to 3 days of continuous hypoxia also exhibit a sustained elevation of CSN activity following return to acute normoxia (18) . A similar "after effect" of continuous hypoxia on sympathetic nerve activity and blood pressure was also reported in healthy humans who returned to sea level after 4 weeks of sojourn at high altitude (64) .
Mechanisms Underlying the Effects of IH on the Carotid Body
Morphology of the carotid body
The carotid body is composed of two major cell types: the type I (also called glomus cells) and type II cells. A substantial body of evidence suggests that type I cells are the initial sites of hypoxic sensing and they work in concert with the nearby afferent nerve endings as a "sensory unit" (99) . Chronic hypoxia results in hyperplasia of the glomus cells and hypertrophy as well as neo-vascularization of the carotid body (39, 66, 88, 102, 156) . However, 10 days of IH exposure had no significant effect either on the number of glomus cells or total volume of the carotid body or glomus cell volume compared to controls (147) . Del Rio et al. (38) also did not find any changes in the carotid body volume and the number of glomus cells in rats exposed to 21 days of IH. However, they found enlarged vascular area and increased size of the blood vessels, without any change in the number of the blood vessels in IH-exposed carotid bodies. The increased size of blood vessels was associated with upregulation of vascular endothelial growth factor (VEGF, 38). Collectively, these studies suggest that changes in the number of glomus cells or morphology of the carotid body do not account for the effects of IH on the carotid body function.
Ex vivo carotid bodies from IH-exposed animals still exhibited sensitization of the hypoxic sensory response as well as sensory LTF similar to those seen in in vivo preparations (147, 153) , suggesting that the altered carotid body function is due to a direct effect of IH on glomus tissue rather than secondary to altered vascular perfusion caused by hypertension.
Glomus cell excitability and ion channels
Glomus cells express a variety of K + channels including calcium-activated, human-ether-gogo (HERG)-like, and TASK-like K + channels (13, 99) . Hypoxia by inhibiting one or more of these K + channels depolarizes glomus cells leading to voltage-gated Ca 2+ influx. The ensuing Ca 2+ -dependent release of excitatory neurotransmitter(s) stimulates the afferent nerve endings resulting in increased sensory discharge (99) . Whether IH affects the excitability of glomus cells was examined.
Ortiz et al. (137) reported that IH had no effect on the resting membrane potential of glomus cells, whereas it increased the hypoxia-induced depolarization by two-fold. Moreover, the magnitude of hypoxia-evoked inhibition of TASK-like K + channels was greater and the time course of the response was faster in IH-exposed glomus cells. It is likely that the enhanced inhibition of TASK-like K + channels and the resulting greater depolarization contribute, in part, to the augmented hypoxic sensory response of the IH-exposed carotid body; whether IH also affects other K + channels in glomus cells remains to be investigated.
Neurotransmitter(s) in IH-Evoked sensitization of the hypoxic sensory response
Carotid body synthesizes and stores a variety of neurotrans-mitters/modulators (159) , which are shown to play important roles in the sensory nerve response to hypoxia (99) . Since the effects of IH on the carotid body are reversible, it was proposed that IH recruits additional neurotransmitters or modulators in the carotid body, which otherwise, play a little or no role in the hypoxic sensory nerve response in control carotid bodies (160).
Endothelin-1 (ET-1)-Endothelin-1 (ET-1) is a vasoactive peptide. Biological actions of ET-1 are mediated via G-protein coupled receptors designated as ET A , ET B , and ET C . Under basal conditions, ET-1 is expressed at very low levels in the carotid body and ET A receptor antagonists had no effect on the hypoxic sensory response (17) , suggesting that ET-1 has a limited or no role in normal carotid body function. However, ET-1 is a potent modulator of the hypoxic sensory response. Exogenous administration of ET-1 augments the hypoxic sensory response without altering the baseline activity in ex vivo carotid bodies, wherein vasoconstrictor effects of the peptide are effectively absent, indicating that ET-1 acts directly on the chemoreceptor tissue (17) . An ET A but not an ET B receptor antagonist prevents the exogenous effects of ET-1 on the rat carotid body (17, 18) . Since plasma levels of ET-1 are elevated in rats exposed to IH (90) and in OSA patients (170) , recent studies examined the role of ET-1 in IH-induced sensitization of the carotid body response to hypoxia.
Iturriaga and co-workers were one of the first to report that IH increases ET-1 expression in the carotid body and bosentan, a pan ET-1 receptor antagonist prevents IH-induced sensitization of the hypoxic sensory response ( Fig. 2; 165-168 ). It was proposed that the transcriptional activator, hypoxia-inducible factor-1 (HIF-1) contributes to IH-induced upregulation of ET-1 in the carotid body (107) . However, Peng et al. (145) found that IH had no effect on pre-pro ET-1 mRNA expression in the carotid body, whereas elevated ET-1 levels were due to increased processing from its precursor, pre-pro endothelin involving activation of the endothelin-converting enzyme (ECE). They further showed that hypoxia facilitates ET-1 release from IH-treated but not from the control carotid body. In IH-exposed carotid bodies, mRNAs encoding ET A receptor were upregulated and an ET A receptor specific antagonist abolished IH-induced hypersensitivity of the carotid body to hypoxia (145) . Exposing rats to more than one week of IH seems to reduce the intensity of ET-1-like immunoreactivity in the carotid body (38) , indicating that ET-1 contributes to the sensitization of the hypoxic response at least in the initial stages of IH exposure.
Interestingly, IH upregulates ET-1 levels in the carotid sinus region of rats, which is the site of baroreceptor nerve endings. The increased ET-1 expression in the carotid sinus region was associated with increased ECE activity, which generates biologically active ET-1 (142) . Carotid baroreceptor responses to elevated sinus pressures were attenuated in IH-exposed rats, and ET A receptor antagonist prevented this response (142) . A similar reduction in baroreflex-regulated sympathetic nerve activity was also reported in healthy humans exposed to 2 weeks of IH (191) . These observations suggest that IH-induced increase in ET-1 on one hand, leads to the sensitization of the carotid body response to hypoxia, whereas it attenuates carotid baroreceptor activity. Since chemoreflex stimulates, whereas baroreflex inhibits sympathetic nerve activity, it was proposed that ET-1-mediated imbalance between carotid chemo-, and baro-reflex contributes to the enhanced sympathetic activation by IH (142) .
Inflammatory cytokines-A recent study reported that IH-exposed carotid bodies exhibit inflammatory phenotype as evidenced by the increase in the number of ED1 positive macrophages (105) . Immunocyto-chemical analysis revealed an increase in the expression of tumor necrosis factor-α, interleukin-1β and accumulation of p65, a Nuclear Factor (NF)-kb subunit in IH-exposed rat carotid bodies (36, 37) . Although ibuprofen prevented IH-induced upregulation of proinflammatory cytokines, it had no effect on the hypersensitivity of the carotid body to hypoxia (36) . Therefore, it is unlikely that the pro-inflammatory cytokines contribute to the IH-evoked heightened carotid body response to hypoxia.
Neurotransmitters mediating the sensory LTF
A subset of neurotransmitters/modulators distinct from those mediating the heightened hypoxic sensitivity seem to contribute to the induction of sensory LTF of the carotid body. Thus, ET A receptor antagonist that prevented the heightened carotid body response to hypoxia, showed no effect on the sensory LTF (142) . Furthermore, mimicking IH with exogenous spaced application of ET-1 was also found to be ineffective in inducing sensory LTF in the control carotid body (142) . Likewise, spaced application of a number of putative excitatory neurochemicals including acetylcholine (ACh), adenosine triphosphate (ATP) and Substance P (SP) as well as KCl, a nonselective depolarizing agent although stimulated the carotid body, but were ineffective in evoking the sensory LTF (149) . In striking contrast, spaced application of 5-hydroxytryptamine (5-HT) or angiotensin II (Ang II) produced a robust sensory LTF in control carotid bodies (149, 151) , suggesting that they contribute to IH-induced sensory LTF. The following section summarizes the studies examining the roles of 5-HT and Ang II in IH-induced sensory LTF.
5-hydroxytryptamine-It is known that 5-hydroxytryptamine (5-HT) evokes long-lasting neuronal activation in the nervous system (116, 121) . Carotid body expresses substantial amounts of 5-HT (84). Peng et al. (146) examined the role of 5-HT in IH-induced sensory LTF. They found that hypoxia facilitates 5-HT release from IH but not from the control carotid bodies. The hypoxiaevoked 5-HT release in IH-exposed carotid body was prevented by 2-APB, a purported ionositol phosphate-3 (IP3) receptor/TRPM2 channel blocker (157) but not by cadmium chloride, a broad-spectrum voltage-gated Ca 2+ channel blocker (146) . These findings suggest that IH evoked 5-HT release involves calcium signaling by IP3 rather than voltage-gated Ca 2+ influx. Mice deficient in the gene encoding the Pet-1 transcription factor exhibit markedly reduced 5-HT expression in the CNS (70, 71) . Pet-1 −/− mice carotid bodies also exhibited a similar absence of 5-HT-like immunoreactivity in glomus cells which is associated with a striking absence of IH-induced sensory LTF (146) . These findings suggest that 5-HT mediates IH-induced sensory LTF.
Angiotensin II-Carotid bodies synthesize angiotensin II (Ang II) via a renin-independent pathway (103) . Glomus cells express angiotensin-converting enzyme (ACE) (104, 112) and angiotensinogen, the precursor of Ang II, as well as angiotensin type 1 receptor (AT1R) (103, 112) . Although the role of Ang II in "normal" carotid body function remains to be established, it has been suggested that Ang II mediates the exaggerated chemoreflex response to hypoxia in experimental models of congestive heart failure (113, 119) . Spaced application of as little as picomolar concentration of Ang II induces robust sensory LTF in control carotid bodies, and this effect was prevented by losartan, an AT1R blocker (149) . A recent study reported that IH upregulates angiotensinogen, ACE and AT1R in rat glomus cells (106) . Taken together, these findings suggest that Ang II also potentially contribute to IH-induced sensory LTF, a possibility that requires further investigation. Since both 5-HT and Ang II produce sensory LTF of the carotid body, it is likely that an interplay between the signaling pathways initiated by these two neuromodulators contribute to IH-induced sensory LTF.
Cellular mechanisms: Reactive oxygen species
It was proposed that reactive oxygen species (ROS) generated during the reoxygenation phase contribute to carotid body responses to IH (160, 197) . ROS levels were increased in IH-exposed carotid bodies as evidenced by decreased aconitase enzyme activity (147) , an in vivo, robust biochemical marker of ROS (56), increased malondialdehyde levels, an index of oxidized lipids (145) and serum 8-isoprostane and nitrotyrosine, markers of oxidative stress (105) . Moreover, treating IH-exposed rats with a stable, membrane permeable superoxide dismutase mimetic, [manganese(III)tetrakis(1-methyl-4-pyridyl)porphyrin pentachloride (MnTMPyP), 5 mg/kg, i.p.], a potent scavenger of ROS completely prevented the sensitization of the hypoxic response and the sensory LTF (147, 148) . Similar effects of other antioxidants on IH-induced carotid body responses were also reported (35) . A single application of MnTMPyP on the last day of IH treatment, instead of daily administration prior to IH, failed to prevent the effects of IH on the carotid body (147) . These findings suggest that ROS-mediated signaling cascade rather than ROS generation per se is critical for carotid body responses to IH. Interestingly, OSA patients also exhibit increased ROS levels as compared with control subjects (21, 188) .
Sources of ROS
Mitochondrial electron-transport chain-One of the cellular sources of ROS generation involve inhibition of complexes I and III of the mitochondrial electron-transport chain (ETC; 2). Biochemical analysis revealed markedly reduced complex I but not the complex III activity in IH-exposed carotid bodies (147) . The decreased complex I activity was associated with increased mitochondrial ROS (93, 197) . Thus, these observations suggest that inhibition of mitochondrial ETC at complex I is an important source of ROS in IH-exposed carotid bodies. Unlike IH, continuous hypoxia inhibits complex III (62), highlighting important differences in mitochondrial sources of ROS generation between both forms of hypoxia.
NADPH oxidases-In addition to the mitochondrial ETC, cytosolic and membrane-bound oxidases constitute important additional sources of ROS (63) . Among them, the Nox family of enzymes including Nox1, 2, 3, and 4 isoforms are major sources of ROS (9) . Carotid bodies express mRNAs encoding all four isoforms of Nox. IH increases Nox2 mRNA levels in the carotid bodies by 35-fold; whereas mRNA levels of Nox1 and Nox3 increased by 16-and 13-fold, respectively (146) . A similar IH-induced increase in Nox2 in the carotid body was also reported by Lam et al. (105) . Nox1 is a homolog of Nox2 (5, 187) . Immunocytochemical analysis revealed that Nox2 and Nox4 protein levels are increased in the cytosol and nuclei, respectively of glomus cells of IH-exposed carotid bodies (146) . Losartan, an AT1R blocker prevented IH-induced upregulation of Nox2 mRNA (106) . IHinduced sensory LTF was absent in mice deficient in gp91 phox , the catalytic subunit of the Nox2 complex as well as following pharmacological blockade of Nox by apocynin or by AEBSF (146) . These observations suggest that IH leads to transcriptional upregulation of Nox2 in the carotid body, which contributes to the induction of sensory LTF. The role of Nox4, which is also upregulated by IH, however, remains to be examined. Khan et al. (93) investigated potential interactions between Nox2 and the mitochondrial complex I. The following findings of this study suggest that ROS generated by Nox2 mediate complex I inhibition by IH: (i) Nox inhibitors or loss of Nox2 function by silencing RNA approach prevent complex I inhibition by IH and (ii) complex I inhibition was absent in IH treated gp91 phox knockout mice. This study further showed that ROS generated by Nox2 facilitates Ca 2+ influx into mitochondria resulting in oxidative modification of the complex I as evidenced by S-glutathionylation of 75-and 50-kDa subunits, which results in inhibition of the complex I activity. After terminating IH, Nox2-mediated ROS generation returned to control levels within 3 h, whereas complex I-mediated ROS generation persisted as long as 16 h (93). These findings suggest that there is a cross-talk between the membrane-bound Nox2 and the mitochondrial complex I leading to ROS-induced ROS (positive "feed-forward" mechanism) resulting in long-lasting ROS generation by IH.
Evidence for ROS-induced ROS-Recently,
Other oxidases-Xanthine oxidoreductase (XO) system is another major source of cellular ROS (122, 123, 134) . It is comprised of xanthine dehydrogenase and XO, which catalyze the oxidation of purines generating superoxide radical as a by product. A recent study reported that XO activation by IH contributes, in part, to increased ROS (128) . Whether XO is also activated in the carotid body by IH, however, has not been examined.
Antioxidant enzymes-Cellular ROS levels depend on the balance between their generation by pro-oxidant enzymes and degradation by antioxidant enzymes. A recent study showed that IH downregulates the Sod2 gene, which encodes superoxide dismutase 2 (Sod2), a major antioxidant enzyme (129) . IH decreases Sod2 enzyme activity in the carotid bodies (129) . These findings suggest that IH-induced oxidative stress in the carotid body is due to increased ROS generation resulting from inhibition of the mitochondrial ETC at complex I, as well as transcriptional upregulation of pro-oxidants like Nox2, with a concomitant downregulation of antioxidant enzymes such as Sod-2.
Molecular mechanisms underlying ROS generation by IH
As mentioned above, the effects of IH on the carotid body develop over time. Generally, the time-dependent changes in the physiological responses are attributed to transcription factormediated gene regulation and the resulting protein products (163) . IH activates a variety of transcription factors, including the HIFs, c-Fos (a component of the activator protein-1 complex, AP1), nuclear factor of activated T-cells (NFAT), and NF-κB (130) . Recent studies demonstrated that transcriptional regulation by HIFs play a critical role in IHinduced ROS generation in the carotid body by affecting the pro-, and anti-oxidant enzyme gene expression.
Hypoxia-inducible factor-1-The transcriptional activator, hypoxia-inducible factor-1 (HIF-1) is a master regulator of O 2 homeostasis during hypoxia that controls multiple physiological processes and it regulates the expression of hundreds of genes (118) . HIF-1 comprises an O 2 -regulated subunit and a constitutive β-subunit (174) . Recent studies showed that IH is a potent activator of HIF-1 in cell cultures (199, 200) , and in the CNS of mice (153) . Although Lam et al. (108) reported that IH increases HIF-1α transcription but not the protein, subsequent studies showed that IH increases HIF-1α protein involving decreased protein degradation by proline hydroxylation, and increased protein synthesis by the mammalian target of rapamycin (25, 199) .
Complete HIF-1α deficiency results in embryonic lethality at mid-gestation, whereas hif1a +/− heterozygous (HET) mice, which are partially deficient in HIF-1α expression, develop normally and are indistinguishable from wild-type (WT) littermates under normoxic conditions (83, 196) . Recent studies examined whether HIF-1 contributes to carotid body responses to IH (153) . Carotid bodies of IH-exposed hif1a +/− mice exhibit remarkable absence of sensitization of the hypoxic sensory response, sensory LTF and unaltered ROS levels; whereas these phenotypic responses were seen in WT mice treated with IH (153) . A recent study reported that HIF-1 mediates transcriptional activation of Nox2 (198) . Therefore, it is likely that activation of HIF-1 by IH contributes to carotid body response to IH via transcriptional upregulation of Nox2, a major pro-oxidant enzyme and the resultant increase in ROS.
Hypoxia-inducible factor-2-Hypoxia-inducible factor-1 (HIF-2α) (also known as endothelial PAS domain protein-1, EPAS-1) is another member of the HIF family (193) . HIF-2α shares ~50% sequence homology to HIF-1α and also interacts with HIF-1β (45) . Continuous hypoxia activates both HIF-1-and HIF-2-mediated transcriptions, which in turn regulate several common target genes (77). Nanduri et al. (129) reported that unlike continuous hypoxia, IH downregulates HIF-2α protein in the carotid body and this effect is mediated by Ca 2+ -dependent protease, calpain. These authors further showed that IHinduced HIF-2α degradation results in transcriptional downregulation of mRNAs encoding several antioxidant enzymes including the Sod-2 in the carotid bodies (144) . Remarkably, hif2a +/− mice exhibit several phenotypic responses that are similar to IH treated WT mice, including augmented carotid body response to hypoxia, elevated blood pressures, increased plasma catecholamines, disrupted breathing manifested by apneas, and oxidative stress (144) . Antioxidant treatment normalizes carotid body function, and restores cardiorespiratory functions of hif2a +/− mice. These observations suggest that down-regulation of HIF-2α contributes to IH-induced elevation of ROS via decreased transcription of antioxidant enzymes.
Thus, the imbalance between HIF-1 and HIF-2 emerges as a major molecular mechanism underlying IH-induced sensitization of the hypoxic response and sensory LTF of the carotid body. Furthermore, HIF-α isoforms also regulate genes encoding various ion channels (163, 171) as well as enzymes involved in the synthesis of transmitters including ACE (163) . Further studies are needed to identify other HIF-dependent target genes in addition to those associated with redox regulation that may also potentially contribute to altered carotid body function by IH. The cellular and molecular mechanisms underlying the effects of IH on the carotid body and the resultant chemoreflex-mediated changes in blood pressure are schematically illustrated in Figure 3 .
How do ROS contribute to IH-induced altered carotid body function?
Recent studies reported that IH-induced increase in ET-1 in the carotid body, which mediates the sensitization of the hypoxic response requires ROS-dependent activation of ECE (142, 145) . In addition, ROS also contributes to hypoxia-induced ET-1 release from IH-exposed carotid bodies (145) . Nox2-derived ROS is also required for the induction of sensory LTF. Nox2 activation in IH-exposed carotid bodies require activation of protein kinase C either by 5-HT2 receptors (146) and/or AT1R (149) . Since IH enhances depolarization of glomus cells involving inhibition of TASK-like K + channels (137) , it remains to be determined whether ROS also play a role in the enhanced glomus cell excitability by IH.
The family of ROS includes superoxide anion (O 2 · − ), and its dismutated product hydrogen peroxide (H 2 O 2 ) as well as hydroxyl radical (OH·). A study by Peng et al. (146) provided important insights into the chemical identity of ROS mediating the effects of IH on the carotid body. Priming the control carotid body with nanomolar concentrations of H 2 O 2 alone is sufficient to evoke both the augmented hypoxic sensory response as well as the induction of sensory LTF by acute IH similar to those observed in IH treated carotid bodies. Treating rats with MnTMPyP, an O 2 · − scavenger, prior to IH completely prevents sensitization of the hypoxic response as well the induction of sensory LTF (147, 148) . However, after the induction of sensory LTF, application of MnTMPyP was ineffective in preventing the maintenance phase of the sensory LTF; whereas, catalase, which degrades H 2 O 2 , effectively blocked the maintenance of sensory LTF in IH treated carotid bodies (146) . These findings taken together suggest that IH-induced remodeling of the carotid body function requires both O 2 · − and its stable dismutated product H 2 O 2 .
IH-induced HIF imbalance and oxidative stress in end organs require sympathetic activation by carotid body chemoreflex
Adrenal medulla is a major end-organ of the sympathetic nervous system. In adult rats, adrenal chromaffin cells are relatively insensitive to the direct effect of hypoxia (192) . However, in IH-exposed rats, hypoxia releases catecholamines from the adrenal medulla by directly acting on chromaffin cells (98) . This IH-induced hypoxic sensitivity of the adrenal chromaffin cells was shown to be due to increased ROS levels (98) . Originally the increased ROS levels were attributed to the direct effect of IH on the adrenal medullary chromaffin cells (AMCs). The IH paradigm employed in this study (98) produced only a modest decrease in arterial blood O2 saturation (~from 97% to 80% or ~20-25 mmHg). Under normoxia although arterial blood pO 2 is ~100 mmHg, pO 2 levels of most tissues including adrenal medulla are much lower and range anywhere between 30 and 60 mmHg (15). Given these low tissue pO 2 levels, modest fluctuations in arterial pO 2 caused by IH may not be sufficient to induce oxidative stress in the adrenal medulla. Peng et al. (152) examined whether carotid body chemoreflex mediates oxidative stress in IH-exposed adrenal medulla. Their results showed that either selective ablation of the carotid body (i.e., removal of the afferent pathway) or chronic ablation of sympathetic innervation to the adrenal medulla (i.e., removal of the efferent pathway) prevented the induction of oxidative stress in the adrenal medulla by IH. These findings suggest that sympathetic activation by the carotid body chemoreflex rather than the direct effect of IH mediates oxidative stress in the adrenal medulla. Analysis of molecular mechanisms revealed that the increased oxidative stress in the adrenal medulla is due to muscarinic acetylcholine receptor-mediated imbalance between HIF-α isoforms resulting in transcriptional dysregulation of pro-, and anti-oxidant enzyme genes. Thus, this study (152) unraveled a hitherto uncharacterized carotid body chemoreflex-dependent regulation of the redox state and HIF-mediated transcriptional regulation in the end-organ such as the adrenal medulla. Moreover, either adrenal demedullation (6) or ablation of the carotid body or sympathetic innervation to the adrenal medulla (152) prevented IH-induced hypertension in rats. These studies suggest that in addition to controlling the vascular tone, chemoreflex mediated sympathetic activation also contributes to IH-induced hypertension by enhancing catecholamine secretion from the adrenal medulla. Whether sympathetic activation by IH also leads to oxidative stress in other end-organs such as blood vessels remains to be studied.
Is the Carotid Body A Therapeutic Target of IH-Induced Hypertension?
As described above, currently available CPAP therapy is ineffective in normalizing blood pressures in a subset of OSA patients with resistant hypertension (43) . Consequently, there is an unmet clinical need for alternative therapeutic strategies for treating hypertension associated with IH resulting from SDB with apnea. Although selective ablation of the carotid body prevented hypertension in a rodent model of IH (52, 109, 152) , use of carotid body ablation as a therapeutic intervention in humans has serious limitations. Carotid body reflexes are critical for a number of physiological functions including high altitude adaptation, maintenance of blood gases during exercise, and cardio-respiratory responses to short-term hypoxia (99) . Consequently, all of these functions will be adversely affected by carotid body ablation. Alternatively, reducing the carotid body hypersensitivity by pharmacological means has the potential to normalize blood pressure in recurrent apnea patients. Since in experimental animal models either antioxidants or blockers of ET A , 5-HT2 and AT1 receptors prevented IH-induced hypersensitivity of the carotid body as well as the sensory LTF (145) (146) (147) (148) 151) , they either alone or in combination with CPAP, could be used as potential therapeutic interventions in controlling blood pressures in recurrent apnea patients. Supporting such a possibility, a recent study reported that valsartan, an antihypertensive medication produced a four-fold higher decrease in mean 24-h blood pressure than CPAP alone in untreated hypertensive patients with OSA (154) . Moreover, recent studies showed that hydrogen sulfide (H 2 S) generated by the enzyme cystathionine-γ-lyase (CSE) is a critical mediator of hypoxic sensing by the carotid body (117, 141) . Interestingly, treating spontaneous hypertensive rats with L-propargylglycine, an inhibitor of CSE, was found to be as effective as carotid body ablation in reducing blood pressures (143) . These observations provide alternative strategy for assessing the efficacy of CSE inhibitor(s) as another potential pharmacological intervention for preventing hypersensitivity of the carotid body and normalizing blood pressures in a subset of recurrent apnea patients.
IH in Neonates
Recurrent apnea is a major clinical problem in infants born preterm (apnea of prematurity). Depending on the gestational age, recurrent apneas are prevalent in nearly 90% of the preterm infants (1, 158) . Infants with recurrent apnea exhibit autonomic dysfunction with clinical signs of over-active sympathetic nervous system (100), altered sympathoadrenal function (101) , augmented ventilatory response to hypoxia (135) , and cardiac arrhythmias (158) .
Carotid body responses to neonatal IH and the underlying mechanisms
Unlike adults, in neonates, hypoxia is not sensed by the carotid bodies because they are developmentally immature (11, 16, 42, 57) . In rats, maturity of the carotid body develops during the first two weeks of life (16, 42, 94) . Perturbations in environmental O 2 in the neonatal period profoundly impact the developmental maturation of the carotid bodies (16, 42, 65) . For instance, exposure of rat pups to either chronic hypoxia (16, 42, 65, 185) or to hyperoxia (10) delays the developmental maturation of the carotid body. On the other hand, carotid bodies from neonatal rat pups exposed to IH exhibit markedly augmented hypoxic sensory response, similar to that seen in adult rats (140, 150; Fig. 4 ). This IH-induced sensitization of the hypoxic sensory response in neonatal rat pups was also shown to be mediated by ROS signaling (139) .
A study by Pawar et al. (140) delineated the following striking differences in the carotid body responses to IH between adult and neonatal rats. First, the magnitude of IH-evoked hypoxic sensitization was significantly greater in neonates than in adults. Second, as short as 8 h of IH was sufficient to evoke sensitization of the hypoxic response in neonatal rat pups as opposed to the requirement of 3 days of IH to elicit a similar response in adults. Third, unlike in adults, IH did not induce sensory LTF in neonatal carotid bodies. Fourth, IH led to hyperplasia of glomus cells in neonates, whereas it had no effect on the number of glomus cells in adult carotid bodies. Fifth, IH-induced hypoxic sensitization and oxidative stress were reversed in adult rats after reoxygenation for 10 days, whereas those induced by neonatal IH persisted into adult life (2 months old). Other mechanisms-The effects of IH on neonatal glomus cells have not yet been investigated. On the other hand, mechanism(s) underlying the cellular effects of neonatal IH had been investigated in neonatal AMCs, which like carotid body glomus cells are also exquisitely sensitive to hypoxia (190, 192) . Souvannakitti et al. (183, 184) reported that IH markedly augments hypoxia-induced exocytosis from neonatal AMC, which is in part due to ROS-induced upregulation of Ca v 3.2 T-type Ca 2+ channels and increased mobilization of intracellular Ca 2+ stores from ryanodine receptors, especially of the RyR2 subtype. Given the similarities between neonatal AMC and carotid body glomus cells, it is likely that similar Ca 2+ signaling mechanisms might also contribute to neonatal IH-induced augmented carotid body hypoxic sensitivity, a possibility that requires further investigation.
Endothelin-1 (ET-1)-Since
Consequences of neonatal IH-induced carotid body hypersensitivity in adult life
As described above, neonatal IH-induced hypersensitivity of the carotid body persisted in adult rats (140) . This effect was associated with elevated plasma catecholamines, hypertension, and irregular breathing with apneas (87, 127) . Therefore, it is conceivable that the augmented chemoreflex contribute to hypertension and respiratory abnormalities in adult rats that were exposed to IH in the neonatal period. Recent clinical studies reported a higher incidence of SDB (75, 138, 169) , hypertension, and insulin resistance (31) in adults who were born preterm than those born full-term. Collectively, the above results suggest that the long-lasting effects of neonatal IH predispose to early onset of cardio-respiratory diseases in adult life.
Epigenetic Programming by Neonatal IH
What mechanisms mediate the long-lasting effects of neonatal IH? Environmental factors during prenatal and early postnatal periods influence developmental programming of homeostatic mechanisms (7, 23, 58) . Emerging evidence suggests that aberrant epigenetic regulation is an underlying mechanism for producing long-lasting effects of environmental perturbations in neonatal life. Epigenetic changes are heritable modifications of DNA including DNA methylation and histone modifications (47, 85) . DNA methylation occurs predominantly on cytosine bases that are part of a 5'-CpG-3' dinucleotide, catalyzed by three DNA methyltransferase enzymes (Dnmts) using S-adenosylmethionine as the methyl donor (46) . DNA hypermethylation leads to repression of gene transcription whereas hypomethylation causes transcriptional activation (176) .
Neonatal IH leads to DNA hypermethylation of antioxidant enzyme genes
A recent study examined the potential role of epigenetic mechanisms involving DNA methylation in the long-lasting effects of neonatal IH on the carotid body (127) . This study reported that the augmented hypoxic sensitivity of the carotid body in adult rats exposed to neonatal IH was associated with persistent oxidative stress, decreased expression of genes encoding antioxidant enzymes, and increased expression of pro-oxidant enzymes. The decreased expression of the Sod2 gene, which encodes the antioxidant enzyme, superoxide dismutase 2 was associated with DNA hypermethylation of a single CpG dinucleotide close to the transcription start site. IH increased the expression of Dnmt 3b, which catalyzes DNA hypermethylation. Treating neonatal rats with decitabine, an inhibitor of DNA methylation, during IH exposure prevented oxidative stress, the enhanced hypoxic sensitivity of the carotid body, and autonomic dysfunction in adult rats. The mechanism(s) contributing to the increased pro-oxidant enzymes, however, remains to be elucidated.
Altered programming of homeostatic mechanisms via epigenetic modulation during perinatal development has been proposed to be the cause of susceptibility to diseases in adulthood (3, 7, 41, 47, 76, 172) . Consistent with this possibility, the above-described findings from the study by Nanduri et al. (127) implicate a hitherto uncharacterized role for epigenetic mechanisms in mediating the long-lasting effects of neonatal IH on the carotid body and the ensuing chemoreflex in initiating the early onset of cardio-respiratory dysfunction in adulthood (Fig. 5) .
Gaps in the knowledge and future directions-Recurrent apnea with IH is a major clinical problem in adults and in preterm infants. Augmented sympathetic nerve activity and hypertension are established comorbidities associated with IH. In this review, we attempted to summarize the impact of IH on hypoxic sensing by the carotid body and the contribution of chemoreflex to sympathetic activation and hypertension. Studies on experimental animal models firmly established that IH profoundly affects the carotid body function which manifested as heightened response to hypoxia in adults and neonates, and sensory LTF in adults. Emerging evidence suggests that dysregulation of transcriptional activators, HIF-1 and HIF-2 and the resulting imbalance in pro-, and anti-oxidant enzyme genes leading to elevated ROS signaling as the major molecular and cellular mechanism, respectively that mediates the effects of IH on the carotid body. Although available evidence suggest that ROS signaling impacts neurotransmitter signaling in the carotid body, little is known on the effects of ROS on glomus cell excitability which is critical for carotid body sensory transduction (99) . Although in adults the effects of short-term IH are reversible, the consequences of long-term IH are yet to be delineated. While a recent study (127) implicates epigenetic mechanisms involving DNA hypermethylation for mediating the long-term effects of neonatal IH, whether histone modifications which represent another important epigenetic mechanism also play a role remain an important area of future research. Future development of new therapeutic interventions targeting the carotid body hypersensitivity to hypoxia has considerable translational potential in controlling resistant hypertension in a subset of OSA patients, and early onset of cardiovascular diseases in adults born preterm. The ex vivo carotid body responses to acute hypoxia (at black bar in left panels) and to acute intermittent hypoxia (AIH; at arrows in right panels) in control and rats exposed to 10 days of intermittent hypoxia (IH). pO 2 = partial pressure of O 2 in the medium irrigating the carotid body. Insets: represent superimposed action potentials of "single" fiber from which the data were derived. Note the augmented hypoxic sensory response and long-lasting increase in baseline activity (sensory LTF) following AIH in IH-exposed carotid bodies.
[From Ref. (162) Schematic illustration of molecular and cellular mechanisms underlying the effects of intermittent hypoxia (IH) on the carotid body and chemoreflex-dependent blood pressure changes. Keys: HIF-1α and HIF-2α, Hypoxia-inducible factor 1 and 2α, respectively; Nox2, NADPH oxidase 2; Sod2, Superoxide dismutase 2; ROS, reactive oxygen species; LTF, long-term facilitation. Schematic illustration of epigenetic mechanisms involving DNA hypermethylation of antioxidant enzymes on neonatal intermittent hypoxia-induced hypertension in adults.
